Title:
Effect of prenatal haloperidol exposure on behavioral alterations in rats

dc.contributor.authorK.P. Singh
dc.contributor.authorMandavi Singh
dc.date.accessioned2026-02-06T10:39:13Z
dc.date.issued2002
dc.description.abstractPregnant Charles-Foster rats were exposed to haloperidol (HAL), a neuroleptic drug that binds to and blocks dopamine (DA) receptor subtypes at a dose of 2.5 mg/kg body weight (intraperitoneally) from Gestation Day (GD) 12 to 20. The animals from both treated as well as vehicle control groups were allowed to deliver on GD 21. The offspring culled at birth on the basis of sex and weight were subjected to behavioral tests at the age of 8 weeks. The HAL-treated rat offspring showed a significant increase in anxiogenic behavior on the open field, elevated plus-maze and elevated zero-maze tests when compared with the vehicle-treated (control) rat offspring of the same age group. These findings suggest that prenatal exposure to HAL during a critical period of brain development leaves a lasting imprint on the brain, resulting in abnormal anxiety states, possibly through dopaminergic neurotransmission mechanisms. © 2002 Published by Elsevier Science Inc.
dc.identifier.doi10.1016/S0892-0362(02)00189-7
dc.identifier.issn8920362
dc.identifier.urihttps://doi.org/10.1016/S0892-0362(02)00189-7
dc.identifier.urihttps://dl.bhu.ac.in/bhuir/handle/123456789/17171
dc.subjectAnxiogenic
dc.subjectHaloperidol
dc.subjectNeurotransmission
dc.subjectPrenatal
dc.titleEffect of prenatal haloperidol exposure on behavioral alterations in rats
dc.typePublication
dspace.entity.typeArticle

Files

Collections